Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have serine-type endopeptidase inhibitor activity. Involved in negative regulation of angiogenesis and negative regulation of epithelial cell proliferation involved in prostate gland development. Localizes to extracellular space. Is expressed in several structures, including alimentary system; central nervous system; genitourinary system; heart; and sensory organ. Used to study osteogenesis imperfecta type 6. Human ortholog(s) of this gene implicated in several diseases, including bone disease (multiple); brain edema; eye disease (multiple); leukostasis; and non-alcoholic steatohepatitis. Orthologous to human SERPINF1 (serpin family F member 1).